CIK 0001728328 · <br>Emerging growth company
InMed Pharmaceuticals Inc.
Sign in to watch- Tickers
- INM MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 669-7207
- Business address
- C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
Securities
- INM Common stock Nasdaq
- MTRI Common Stock Nasdaq
- 8-K Event Material agreement · Acquisition or sale completed · Results of operations · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change
- 4 Open-market buy 10% owner bought 2,640 shares at $13.10 ($34,572)
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change · Shareholder vote results · Other events
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 425 Deal Prospectus/Communication re Business Combination
- 424B3 Offering Prospectus
- 4 Insider Changes in Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- S-4/A Deal Registration Statement - Business Combination
- 8-K Event Delisting notice · Other events
Page 1 of 26 · 517 filings